Patents by Inventor Anat Aharon

Anat Aharon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • EXTRACELLULAR VESICLES DERIVED FROM ACTIVATED CAR-T CELLS
    Publication number: 20220204928
    Abstract: The present invention provides extracellular vesicles (EVs) derived from T-cells expressing chimeric antigen receptors (CAR) specifically activated with an antigen to which the CAR bind specifically, pharmaceutical compositions comprising these vesicles as well as their use in treating cancer. In particular the present invention exemplifies EVs derived from activated T-cells expressing CAR that bind specifically to HER2 cancer antigen, pharmaceutical composition comprising these EVs and their use in treating a cancer overexpressing HER2, such as ovarian cancer and breast cancer.
    Type: Application
    Filed: April 16, 2020
    Publication date: June 30, 2022
    Inventors: Anat AHARON, Anat GLOBERSON LEVIN, Irit AVIVI, Galit HORN, Tova WAKS, Zelig ESHHAR
  • TROPHOBLAST DERIVED MICROPARTICLES FOR TREATING ISCHEMIC TISSUE AND WOUNDS
    Publication number: 20160175364
    Abstract: The invention relates to pharmaceutical compositions comprising trophoblast derived microparticles for the treatment of damaged tissue, including, ischemic tissue and wounds.
    Type: Application
    Filed: July 28, 2014
    Publication date: June 23, 2016
    Inventors: Anat AHARON, Lior GEPSTEIN, Benjamin BRENNER
  • METHODS AND KITS FOR ISOLATING PLACENTAL DERIVED MICROPARTICLES AND USE OF SAME FOR DIAGNOSIS OF FETAL DISORDERS
    Publication number: 20120129183
    Abstract: A prenatal method of analyzing a fetus is disclosed. The method comprising: (a) isolating placental derived microparticles; and (b) analyzing at least one component of the contents of the placental derived microparticles, wherein the at least one component is indicative of a characteristic of the fetus.
    Type: Application
    Filed: June 24, 2010
    Publication date: May 24, 2012
    Applicants: RAPPAPORT FAMILY INSTITUTE FOR RESEARCH IN THE MEDICAL SCIENCES, FUND FOR MEDICAL RESEARCH DEVELOPMENT OF INFRASTRUCTURE AND HEALTH SERVICES
    Inventors: Anat Aharon, Benjamin Brenner
  • Methods and Kits for Determining Blood Coagulation
    Publication number: 20090042217
    Abstract: A method of determining a coagulation status of a blood sample is provided. The method comprising determining an expression and/or activity ratio of Tissue Factor (TF) to Tissue Factor Pathway Inhibitor (TFPI) in cellular microparticles of the blood sample, wherein the ratio is indicative of the coagulation status of the blood sample.
    Type: Application
    Filed: June 23, 2008
    Publication date: February 12, 2009
    Applicant: Rappaport Family Institute for Research in the Medical Sciences
    Inventors: Benjamin Brenner, Anat Aharon